Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Researchers to develop new technology to detect and remove cancer tumors

New technology that will marry probes that can detect cancer tumors through the skin with high-precision robotic surgery is to be developed for use in hospital settings for the first time in a project led by the University of Warwick.

7 Jun 2021

Researchers analyze transparency, variation of payer-negotiated prices for thyroid cancer treatment

Hospital price transparency is intended to help inform patients about the cost of services and procedures before they receive them. Since Jan. 1, 2021, hospitals in the U.S. have been required by The Centers for Medicare and Medicaid Services (CMS) to provide pricing information online about items and services.

5 Jun 2021

New nano-sized particles help improve detection of tumors within the body

Nano-sized particles have been engineered in a new way to improve detection of tumors within the body and in biopsy tissue, a research team in Sweden reports. The advance could enable identifying early stage tumors with lower doses of radiation.

3 Jun 2021

Doctors tell how to make the most of your telehealth visits

When the pandemic sidelined in-office visits at his practice, Dr. Dael Waxman "wasn't exactly thrilled with being at home." But he quickly shifted gears to video and telephone appointments.

2 Jun 2021

New project aims to develop technologies for quantifying cancer and viral biomarkers

Liquid biopsy, the detection of circulating disease biomarkers in bodily fluids such as blood, is a non-invasive method, alternative to tissue removal, which has taken important strides toward the implementation of personalized medicine, especially in the case of tumors and RNA-viruses.

1 Jun 2021

The LUCA device shows high accuracy in thyroid cancer screening

Thyroid nodules are a common pathology having a prevalence of 19-76% when screened with ultrasound, with higher frequencies in women.

1 Jun 2021

New AI tool predicts the extent of chronic damage in the kidney

Chronic kidney disease (CKD) is caused by diabetes and hypertension. In 2017, the global prevalence of CKD was 9.1 percent, which is approximately 700 million cases.

24 May 2021

Doctors now must provide patients their health data, online and on demand

Last summer, Anna Ramsey suffered a flare-up of juvenile dermatomyositis, a rare autoimmune condition, posing a terrifying prospect for the Los Angeles resident: She might have to undergo chemotherapy, further compromising her immune system during a pandemic.

18 May 2021

Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic

Owlstone Medical today announced agreements with Functional Gut Clinic ("FGC") and Functional Gut Diagnostics (“FGD”).

From Owlstone Medical Ltd 18 May 2021

Personalized vaccine can provide effective immunization against cancer

Marie-Claude Bourgeois-Daigneault and her team at the CRCHUM are using mice to show how a combination of peptides and oncolytic viruses, used as an adjuvant, can provide effective immunization against cancer.

11 May 2021

CHEST releases new clinical guidelines to improve diagnosis of hypersensitivity pneumonitis

The American College of Chest Physicians recently released new clinical guidelines on the Diagnosis and Evaluation of Hypersensitivity Pneumonitis (HP).

10 May 2021

Study provides new insight on how HER2-low tumors may evolve in breast cancer patients

The finding that breast tumors can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low tumors.

8 May 2021

Researchers use 3-D bioprinting to create custom-shaped cartilage for use in surgical procedures

A team of University of Alberta researchers has discovered a way to use 3-D bioprinting technology to create custom-shaped cartilage for use in surgical procedures. The work aims to make it easier for surgeons to safely restore the features of skin cancer patients living with nasal cartilage defects after surgery.

5 May 2021

Researchers develop new technology to reduce high error rates in gene sequencing

Next-generation gene sequencing (NGS) technologies --in which millions of DNA molecules are simultaneously but individually analyzed-- theoretically provides researchers and clinicians the ability to noninvasively identify mutations in the blood stream.

4 May 2021

Cell-free DNA tests can reduce the need for biopsies to detect rejection after heart transplant

A new study, presented today at the AATS 101st Annual Meeting, shows that non-invasive cell-free DNA tests can reduce the need for regular surveillance biopsies to detect early rejection in heart transplant patients. The study was the first of its kind to be performed on both adult and pediatric patients.

30 Apr 2021

Thousands of men to trial new home test kit for prostate cancer

Thousands of men worldwide are to receive a home test kit for prostate cancer – thanks to pioneering research from the University of East Anglia and the Norfolk and Norwich University Hospital (NNUH).

30 Apr 2021

Study evaluates first tumor-uninformed ctDNA assay to detect residual cancer cells after treatment

After patients with cancer undergo surgery to remove a tumor and sometimes additional chemotherapy, tools are used to identify patients at highest risk of recurrence.

30 Apr 2021

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, is now recruiting patients for a Phase 2 clinical trial to investigate whether pills containing white button mushroom extract could regulate the immune system, affecting prostate-specific antigen (PSA) levels to either remain stable or decline.

29 Apr 2021

New urine test for prostate cancer shows aggressiveness of the disease

Researchers from the University of East Anglia have developed a new urine test for prostate cancer which also shows how aggressive the disease is.

27 Apr 2021

Hypoxia radioactive marker will detect aggressiveness of tumors, eliminating the need for biopsy

Scientific advances in cancer research and new means of diagnosis and treatment have made it possible to cure many patients.

26 Apr 2021

Biopsy News and Research

Further Reading

Researchers to develop new technology to detect and remove cancer tumors

Researchers analyze transparency, variation of payer-negotiated prices for thyroid cancer treatment

New nano-sized particles help improve detection of tumors within the body

Doctors tell how to make the most of your telehealth visits

New project aims to develop technologies for quantifying cancer and viral biomarkers

The LUCA device shows high accuracy in thyroid cancer screening

New AI tool predicts the extent of chronic damage in the kidney

Doctors now must provide patients their health data, online and on demand

Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic

Personalized vaccine can provide effective immunization against cancer

CHEST releases new clinical guidelines to improve diagnosis of hypersensitivity pneumonitis

Study provides new insight on how HER2-low tumors may evolve in breast cancer patients

Researchers use 3-D bioprinting to create custom-shaped cartilage for use in surgical procedures

Researchers develop new technology to reduce high error rates in gene sequencing

Cell-free DNA tests can reduce the need for biopsies to detect rejection after heart transplant

Thousands of men to trial new home test kit for prostate cancer

Study evaluates first tumor-uninformed ctDNA assay to detect residual cancer cells after treatment

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

New urine test for prostate cancer shows aggressiveness of the disease

Hypoxia radioactive marker will detect aggressiveness of tumors, eliminating the need for biopsy

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News